Guangdonghectechnologyholdingco.Ltd(600673) : Guangdonghectechnologyholdingco.Ltd(600673) plans to acquire the equity of Guangdong Guangdonghectechnologyholdingco.Ltd(600673) Pharmaceutical Co., Ltd. and the appraisal report of 5.14% equity value assets of Guangdong Guangdonghectechnologyholdingco.Ltd(600673) Pharmaceutical Co., Ltd

The assets appraisal report is prepared in accordance with China's assets appraisal standards

Guangdonghectechnologyholdingco.Ltd(600673) proposed acquisition

Equity of Guangdong Guangdonghectechnologyholdingco.Ltd(600673) Pharmaceutical Co., Ltd

5.14% equity value of Guangdong Guangdonghectechnologyholdingco.Ltd(600673) Pharmaceutical Co., Ltd

assets valuation statement

United Zhonghe pingbao Zi (2022) No. 6020

(Volume 1 of 1)

United Zhonghe Land Real Estate Assets Appraisal Co., Ltd

March 14, 2002

catalogue

Declare that- 3 - Summary- 5 - text- 18 - I. overview of the client, the appraised entity and the users of other asset appraisal reports agreed in the asset appraisal entrustment contract - 18-

2、 Evaluation purpose- 46 - III. appraisal object and scope- IV. definition and types of value- 52 - V. appraisal base date- 52 - VI. evaluation basis- 52 - VII. Evaluation method- 55 - VIII. Application of specific evaluation methods of various assets and liabilities in the asset based method- 58 - IX. implementation process and situation of the evaluation procedure- 68 - X. evaluation assumptions- 70 - Xi. Appraisal conclusion- 72 - XII. Description of special matters- 73 - XIII. Description of restrictions on the use of the appraisal report- 86 - XIV. Date of assets appraisal report- 87 - attachment of asset appraisal report- 89 -

United Zhonghe Land Real Estate Assets Appraisal Co., Ltd. page 2 of 89

Statement

1、 The assets appraisal report is prepared in accordance with the basic standards for assets appraisal issued by the Ministry of finance of the people's Republic of China and the asset appraisal practice standards and professional ethics standards issued by China Assets Appraisal Association.

2、 The client or other users of the asset appraisal report shall use the asset appraisal report according to law in accordance with the provisions of laws, administrative regulations and the scope of use specified in the asset appraisal report; If the client or other users of the asset appraisal report use the asset appraisal report in violation of the above provisions, the asset appraisal institution and the signing asset appraiser shall not be liable.

3、 This asset appraisal report is only for the use of the client, other users of asset appraisal reports agreed in the asset appraisal entrustment contract and users of asset appraisal reports stipulated by national laws and administrative regulations; In addition, no other institution or individual can become the user of the asset appraisal report.

4、 The user of the asset appraisal report shall correctly understand and use the appraisal conclusion. The appraisal conclusion is not equal to the realizable price of the appraisal object, and the appraisal conclusion shall not be regarded as a guarantee for the realizable price of the appraisal object.

5、 The analysis, judgment and results in the asset appraisal report issued by the asset appraisal institution are limited by the assumptions and restrictions in the asset appraisal report; The user of the asset appraisal report shall pay full attention to and consider the assumptions, restrictions, special matters and their impact on the appraisal conclusion stated in the asset appraisal report, and use the appraisal conclusion reasonably according to law.

6、 The asset appraisal institution and its asset appraisal professionals abide by laws, administrative regulations and asset appraisal standards, adhere to the principles of independence, objectivity and impartiality, and bear responsibility for the asset appraisal report issued according to law.

7、 The list of assets and liabilities involved in the appraisal object shall be declared by the client and relevant parties and confirmed by signature, seal or other methods permitted by law; The client and relevant parties shall be responsible for the authenticity, legality and integrity of the materials provided by them according to law; The legal consequences caused by the false or untrue legal ownership materials, financial and accounting information or other relevant materials provided by the client and relevant parties and the failure of asset appraisal professionals to find them during the normal verification procedures shall be borne by the client and relevant parties according to law.

8、 There is no existing or expected interest relationship between the asset appraisal institution and the asset appraisal professionals executing the project and the appraisal object in the asset appraisal report; There is no existing or expected interest relationship with the relevant parties, and there is no prejudice against the relevant parties.

9、 The asset appraisal professionals have conducted necessary on-site investigation on the appraisal object and the assets involved in the asset appraisal report; The legal ownership status and data of the appraisal object and the assets involved have been checked, and the defects of the property right data found have been truthfully disclosed, but it is not for the appraisal object

United Zhonghe Land Real Estate Assets Appraisal Co., Ltd. page 3 of 89

Guarantee of legal ownership. The client and relevant parties are hereby requested to improve the property right procedures to meet the requirements of economic behavior in the asset appraisal report.

10、 If there is a mantissa difference between the total amount of 10000 yuan and the total amount of detailed data in this asset appraisal report, it is due to the fact that the computer follows the rounding rule when rounding the detailed data of 10000 yuan, and the summarized data shall prevail.

Explain that if the asset appraisal professionals have performed the appraisal procedures and are still unable to know, the asset appraisal institution and asset appraisal professionals will not bear relevant responsibilities.

(II) the behavior documents, business licenses, property rights certificates, financial statements, accounting vouchers and other materials required for the evaluation provided by Guangdong Guangdonghectechnologyholdingco.Ltd(600673) Pharmaceutical Co., Ltd. are the basis for the preparation of this report. The client and relevant parties shall be responsible for the authenticity, legality and integrity of the materials provided.

(III) the asset appraisal professionals have carried out necessary verification on the property rights of the assets within the scope of entrustment and fully disclosed the problems found in the property rights of the assets as far as possible. No property rights disputes are found in this appraisal, but the appraisal report is a professional appraisal opinion on the appraisal object and does not have the legal attribute of property rights certificate. Therefore, This report cannot be used as a proof of property rights.

(IV) incomplete or defective information on asset ownership

1. As of the benchmark date of the appraisal, 2 houses and buildings declared for appraisal by Guangdong Guangdonghectechnologyholdingco.Ltd(600673) pharmaceutical industry have not yet obtained the property right certificate, and the details of the houses and buildings that have not obtained the certificate are as follows:

Serial number house name house structure completion time house area (m) ²)

1 dormitory building AB steel concrete building 201512-31565043

2 guard room mixed 200612-31 32.00

For the unlicensed house, Guangdong Guangdonghectechnologyholdingco.Ltd(600673) pharmaceutical declared the area of the house and promised that the company owns the ownership of the house without certificate and has no property right dispute with any third party. If all legal consequences caused by the property right dispute are borne by the company.

The appraisers confirmed the legal property right and building area of the building based on the relevant materials provided by the appraised unit, without considering the impact of possible property right disputes and the inconsistency between the declared area and the final certified area on the appraisal conclusion.

2. The two patent rights declared by the company are North South brothers pharmaceutical investment Co., Ltd. as of the benchmark date, the above patent rights have been transferred to Guangdong Guangdonghectechnologyholdingco.Ltd(600673) Pharmaceutical Co., Ltd. free of charge and are in the process of changing the obligee. The details are as follows:

Application No. application date case name national patent application project applicant

(region) status type name

P Huangshan Novel Co.Ltd(002014) 0 dihydropyrimidine derivative India Dongan Nanbei brothers pharmaceutical investment 8325 crystal form Nisi authorized invention dizi Co., Ltd. Asia on September 27, 2013

Pid20170 dihydropyrimidine derivative Indian patent Dongan Nanbei brothers pharmaceutical investment 60372016-02-02 salt and its application in the pharmaceutical Nisi maintenance invention Kangzi Co., Ltd

As of the appraisal date, Guangdong pharmaceutical has the following trademark use rights:

United Zhonghe Land Real Estate Assets Appraisal Co., Ltd. page 6 of 89

merchant

Case name case product application No. application date Registration No. registration date applicant

Called state class

other

Yangjianrun authorized 534850852018-11-234850852019-07-14 Yichang Guangdonghectechnologyholdingco.Ltd(600673) Changjiang Pharmaceutical Co., Ltd

Yangantuo authorized 53332378 September 0, 20183332378 June 7, 2019 Yichang Guangdonghectechnologyholdingco.Ltd(600673) Changjiang Pharmaceutical Co., Ltd

Yang Jianrui authorized 533323332018-09-033323332019-06-07 Yichang Guangdonghectechnologyholdingco.Ltd(600673) Changjiang Pharmaceutical Co., Ltd

New "East 19533202016-08-11953320 Yichang Guangdonghectechnologyholdingco.Ltd(600673) Changjiang Pharmaceutical Co., Ltd. sunshine" authorization 5 6 8 6 201705-21 Co., Ltd

Without loop

Guangdonghectechnologyholdingco.Ltd(600673) authorized 526725152017-09-326725152019-01-14 Yichang Guangdonghectechnologyholdingco.Ltd(600673) Changjiang Pharmaceutical Co., Ltd

HEC + 13913352014-01-11391335 Yichang Guangdonghectechnologyholdingco.Ltd(600673) Changjiang Pharmaceutical Co., Ltd

shape

Xuxin authorized 584281082010-06-284281082011-07-14 Shenzhen Guangdonghectechnologyholdingco.Ltd(600673) Industrial Development Co., Ltd

Weisu authorized 584281072010-06-284281072011-07-14 Shenzhen Guangdonghectechnologyholdingco.Ltd(600673) Industrial Development Co., Ltd

Hanle authorized 584281182010-06-284281182011-07-14 Shenzhen Guangdonghectechnologyholdingco.Ltd(600673) Industrial Development Co., Ltd

Xinshuwei authorized 584272892010-06-284272892011-07-14 Shenzhen Guangdonghectechnologyholdingco.Ltd(600673) Industrial Development Co., Ltd

Kelisha authorization 584272872010-06-284272872011-07

- Advertisment -